133 related articles for article (PubMed ID: 32426524)
1. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy.
Kenna PF; Humphries MM; Kiang AS; Brabet P; Guillou L; Ozaki E; Campbell M; Farrar GJ; Koenekoop R; Humphries P
BMJ Open Ophthalmol; 2020; 5(1):e000462. PubMed ID: 32426524
[TBL] [Abstract][Full Text] [Related]
2. Properties and Therapeutic Implications of an Enigmatic D477G RPE65 Variant Associated with Autosomal Dominant Retinitis Pigmentosa.
Kiang AS; Kenna PF; Humphries MM; Ozaki E; Koenekoop RK; Campbell M; Farrar GJ; Humphries P
Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33261050
[TBL] [Abstract][Full Text] [Related]
3. Insights into the pathogenesis of dominant retinitis pigmentosa associated with a D477G mutation in RPE65.
Choi EH; Suh S; Sander CL; Hernandez CJO; Bulman ER; Khadka N; Dong Z; Shi W; Palczewski K; Kiser PD
Hum Mol Genet; 2018 Jul; 27(13):2225-2243. PubMed ID: 29659842
[TBL] [Abstract][Full Text] [Related]
4. Gene Supplementation in Mice Heterozygous for the D477G RPE65 Variant Implicated in Autosomal Dominant Retinitis Pigmentosa.
Feathers KL; Jia L; Khan NW; Smith AJ; Ma JX; Ali RR; Thompson DA
Hum Gene Ther; 2023 Jul; 34(13-14):639-648. PubMed ID: 37014074
[TBL] [Abstract][Full Text] [Related]
5. Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial.
Koenekoop RK; Sui R; Sallum J; van den Born LI; Ajlan R; Khan A; den Hollander AI; Cremers FP; Mendola JD; Bittner AK; Dagnelie G; Schuchard RA; Saperstein DA
Lancet; 2014 Oct; 384(9953):1513-20. PubMed ID: 25030840
[TBL] [Abstract][Full Text] [Related]
6. Environmental Light Has an Essential Effect on the Disease Expression in a Dominant RPE65 Mutation.
Wu W; Takahashi Y; Ma X; Moiseyev G; Ma JX
Adv Exp Med Biol; 2023; 1415():415-419. PubMed ID: 37440066
[TBL] [Abstract][Full Text] [Related]
7. A Dominant Mutation in Rpe65, D477G, Delays Dark Adaptation and Disturbs the Visual Cycle in the Mutant Knock-In Mice.
Shin Y; Moiseyev G; Chakraborty D; Ma JX
Am J Pathol; 2017 Mar; 187(3):517-527. PubMed ID: 28041994
[TBL] [Abstract][Full Text] [Related]
8. Intervisit variability of visual parameters in Leber congenital amaurosis caused by RPE65 mutations.
Roman AJ; Cideciyan AV; Schwartz SB; Olivares MB; Heon E; Jacobson SG
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1378-83. PubMed ID: 23341016
[TBL] [Abstract][Full Text] [Related]
9. Two-year progression analysis of RPE65 autosomal dominant retinitis pigmentosa.
Jauregui R; Park KS; Tsang SH
Ophthalmic Genet; 2018 Aug; 39(4):544-549. PubMed ID: 29947567
[TBL] [Abstract][Full Text] [Related]
10. Safety and Proof-of-Concept Study of Oral QLT091001 in Retinitis Pigmentosa Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT).
Scholl HP; Moore AT; Koenekoop RK; Wen Y; Fishman GA; van den Born LI; Bittner A; Bowles K; Fletcher EC; Collison FT; Dagnelie G; Degli Eposti S; Michaelides M; Saperstein DA; Schuchard RA; Barnes C; Zein W; Zobor D; Birch DG; Mendola JD; Zrenner E;
PLoS One; 2015; 10(12):e0143846. PubMed ID: 26656277
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal and cross-sectional study of patients with early-onset severe retinal dystrophy associated with RPE65 mutations.
Paunescu K; Wabbels B; Preising MN; Lorenz B
Graefes Arch Clin Exp Ophthalmol; 2005 May; 243(5):417-26. PubMed ID: 15565294
[TBL] [Abstract][Full Text] [Related]
12. A dominant mutation in RPE65 identified by whole-exome sequencing causes retinitis pigmentosa with choroidal involvement.
Bowne SJ; Humphries MM; Sullivan LS; Kenna PF; Tam LC; Kiang AS; Campbell M; Weinstock GM; Koboldt DC; Ding L; Fulton RS; Sodergren EJ; Allman D; Millington-Ward S; Palfi A; McKee A; Blanton SH; Slifer S; Konidari I; Farrar GJ; Daiger SP; Humphries P
Eur J Hum Genet; 2011 Oct; 19(10):1074-81. PubMed ID: 21654732
[TBL] [Abstract][Full Text] [Related]
13. Longevity of visual improvements following transcorneal electrical stimulation and efficacy of retreatment in three individuals with retinitis pigmentosa.
Bittner AK; Seger K
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):299-306. PubMed ID: 29222719
[TBL] [Abstract][Full Text] [Related]
14. Aberrant RNA splicing is the major pathogenic effect in a knock-in mouse model of the dominantly inherited c.1430A>G human RPE65 mutation.
Li Y; Furhang R; Ray A; Duncan T; Soucy J; Mahdi R; Chaitankar V; Gieser L; Poliakov E; Qian H; Liu P; Dong L; Rogozin IB; Redmond TM
Hum Mutat; 2019 Apr; 40(4):426-443. PubMed ID: 30628748
[TBL] [Abstract][Full Text] [Related]
15. Clinical trial design for neuroprotection in
Otte B; Andrews C; Lacy G; Branham K; Musch DC; Jayasundera KT
Ophthalmic Genet; 2021 Apr; 42(2):170-177. PubMed ID: 33406961
[No Abstract] [Full Text] [Related]
16. Phenotypic conservation in patients with X-linked retinitis pigmentosa caused by RPGR mutations.
Zahid S; Khan N; Branham K; Othman M; Karoukis AJ; Sharma N; Moncrief A; Mahmood MN; Sieving PA; Swaroop A; Heckenlively JR; Jayasundera T
JAMA Ophthalmol; 2013 Aug; 131(8):1016-25. PubMed ID: 23681342
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 9-cis-retinyl acetate therapy in Rpe65-/- mice.
Maeda T; Maeda A; Casadesus G; Palczewski K; Margaron P
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4368-78. PubMed ID: 19407008
[TBL] [Abstract][Full Text] [Related]
18. The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 Gene.
Chung DC; Bertelsen M; Lorenz B; Pennesi ME; Leroy BP; Hamel CP; Pierce E; Sallum J; Larsen M; Stieger K; Preising M; Weleber R; Yang P; Place E; Liu E; Schaefer G; DiStefano-Pappas J; Elci OU; McCague S; Wellman JA; High KA; Reape KZ
Am J Ophthalmol; 2019 Mar; 199():58-70. PubMed ID: 30268864
[TBL] [Abstract][Full Text] [Related]
19. Phenotype associated with mutation in the recently identified autosomal dominant retinitis pigmentosa KLHL7 gene.
Hugosson T; Friedman JS; Ponjavic V; Abrahamson M; Swaroop A; Andréasson S
Arch Ophthalmol; 2010 Jun; 128(6):772-8. PubMed ID: 20547956
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Amelioration of Cone Survival and Vision in a Mouse Model for Leber Congenital Amaurosis.
Li S; Samardzija M; Yang Z; Grimm C; Jin M
J Neurosci; 2016 May; 36(21):5808-19. PubMed ID: 27225770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
